Highest-materiality recent filing
Stockholders approved the Nasdaq issuance proposal tied to the TCW financing, with 44,411,409 votes for and 3,910,714 against.
Accuray Q4 revenue down 21% YoY; FY26 net loss $49.2M; TCW financing closes
Q4 revenue $100.9M (-21% YoY); product revenue $40.8M (-42%), service revenue $60.1M (+6%).
Accuray transfers listing to Nasdaq Capital Market; gets 180-day bid price extension
Common stock transferred from Nasdaq Global Select to Nasdaq Capital Market effective August 6, 2026.
Accuray restructures with TCW: $40M debt to preferred, $15M cash, covenant holiday through 2027
TCW exchanges $40M term loan for convertible preferred stock at $0.50/share (105.4% premium to prior close), 8% dividend.
Accuray Q3 revenue down 7% to $104.8M; net loss $11.8M; withdraws FY2026 guidance
Net loss of $11.8M ($0.09 per share) vs $1.3M loss YoY; Adjusted EBITDA $3.8M vs $6.0M.
Accuray non-reliance on FY2025 and Q1 FY2026 financials over RPO footnote errors; no P&L impact
Audit committee concluded audited FY2025 10-K and interim 10-Qs for FY2025 and Q1 FY2026 should no longer be relied upon due to RPO disclosure errors.
Accuray receives Nasdaq deficiency notice for bid price below $1; 180-day cure period
Received Nasdaq notice on Feb 2, 2026 for non-compliance with $1 minimum bid price rule.
Accuray Q2 net loss $0.11 per share; revenue down 12%; launches $25M transformation plan
Total net revenue $102.2M, down 12% YoY; product revenue fell 26% to $45.0M, service revenue up 4% to $57.2M.
Workforce reduction of ~15% global headcount; total restructuring charges estimated at ~$11M, mostly cash.
Accuray Q1 revenue down 7%, net loss widens to $21.7M; CEO replaced, restructuring initiated
Revenue $93.9M (-7% YoY); product revenue $37.2M (-23%); service revenue $56.8M (+7%).
Accuray appoints Steve La Neve as CEO; prelim Q1 rev $92.5-94M, adj EBITDA ~($4M)
Steve La Neve appointed President & CEO effective Oct 20, 2025; succeeds Suzanne Winter who retired.
Accuray Q4 revenue $127.5M (-5% YoY); full year net loss narrows to $1.6M
Q4 revenue $127.5M, down 5% YoY; product revenue $70.7M (-11%), service revenue $56.8M (+4%).
Accuray refinances debt: $150M term loan from TCW, exchanges $82M notes for stock & cash
Exchanged ~$82M of 3.75% convertible notes for 8.88M shares and ~$68.6M cash; $18M of notes remain outstanding.
Accuray Q3 revenue $113.2M (+12% YoY); FY revenue guidance cut to $452-460M on tariffs
Q3 net loss narrowed to $1.3M ($0.01/sh) from $6.3M ($0.06/sh) a year ago; adjusted EBITDA rose to $6.0M from $1.1M.
Accuray Q2 FY2025 revenue up 8% to $116.2M, net income $2.5M; raises FY guidance
Revenue $116.2M (+8% YoY); net income $2.5M ($0.03 EPS) vs loss $9.6M ($0.10 loss) prior year.
Accuray reports Q1 FY2025 revenue $101.5M, net loss $4.0M; raises full-year guidance
Revenue $101.5M (down 2% YoY); service revenue grew to $53.2M (+5% YoY) offsetting product decline.
Accuray CEO Suzanne Winter takes temporary medical leave; Sandeep Chalke named interim CEO
CEO Suzanne Winter taking temporary medical leave to treat a treatable form of cancer, effective September 3, 2024.
Accuray Q4 revenue up 13.5% to $134.3M; posts net income of $3.4M; FY25 guidance issued
Q4 revenue $134.3M (+13.5% YoY); GAAP net income $3.4M vs loss $2.6M; Adj EBITDA $10.1M vs $5.2M.
Accuray Q3 revenue down 14% to $101.1M; net loss $6.3M vs prior income $0.6M
Net revenue $101.1M (-14% YoY); product $49.6M, service $51.5M.
Accuray Q2 revenue falls 7% to $107.2M, net loss widens; orders up 19%
GAAP net loss $9.6M ($0.10/sh) vs $1.9M loss a year ago; adjusted EBITDA $2.0M down from $8.5M.
Accuray Q1 revenue $103.9M (+7.7% YoY), net loss narrows to $3M, reaffirms FY2024 outlook
Revenue $103.9M (+7.7% YoY); product rev $53.4M (+19.7%), service rev $50.5M (-2.7%).
Accuray Q4 revenue $118.3M (+7.5%); FY GAAP net loss $9.3M vs $5.3M prior year
Q4 net revenue $118.3M (+7.5% YoY); GAAP net loss $2.6M ($0.03/share) vs loss $3.5M prior year.
Accuray Q3 revenue $118.1M (+22.8% YoY), net income $0.6M, record 30 systems shipped
Record quarterly revenue $118.1M, up 22.8% YoY; constant currency revenue $122.1M (+27%).
On October 8, 2026, Mika Nishimura, a Class II director of Accuray Incorporated (the “Company”), informed the Company’s Board of Directors (the “Board”) of her intention not to stand for re-election at the Company’s 2026 annual meeting of stockholders to be held in November 2026 (the “Annual Meeting”).
On October 5, 2026, the Board of Directors (the “Board”) of Accuray Incorporated (the “Company”) appointed Richard A. Meier to the Board as a Class II director, with a term expiring at the Company’s 2026 annual meeting of stockholders.
Leonel Peralta, Senior Vice President, Chief Operations Officer of Accuray Incorporated (the “Company”), departed from the Company effective April 26, 2026.
On June 3, 2025, the Board appointed Steven F. Mayer to the Board as a Class III director, with a term expiring at the Company’s 2027 annual meeting of stockholders, effective immediately prior to, and contingent upon, the effectiveness of the Financing Agreement.
The Board of Directors of Accuray Incorporated (the “Company”) appointed Leonel Peralta as the Company’s Senior Vice President, Chief Operations Officer, effective February 3, 2025.
On November 21, 2024, the Company’s Board of Directors appointed Michael Murphy, 45, as the Company’s principal accounting officer, effective December 2, 2024.
Sandeep Chalke, who served as the Company’s interim Chief Executive Officer, will continue to serve as the Company’s Senior Vice President, Chief Commercial Officer.
On October 15, 2024, Accuray Incorporated (the “Company”) announced that Suzanne Winter, the Company’s Chief Executive Officer and President, has returned from her medical leave of absence and reassumed her duties as the Company’s Chief Executive Officer and President, effective the same date.
On August 28, 2024, Suzanne Winter, President and Chief Executive Officer of Accuray Incorporated (the “Company”) informed the board of directors of the Company (the “Board”) that she is taking a temporary medical leave of absence, effective September 3, 2024.
On August 30, 2024, in connection with Ms. Winter’s leave of absence and effective September 3, 2024, the Board appointed Sandeep Chalke, the Company’s Chief Commercial Officer, as the Company’s interim Chief Executive Officer and interim principal executive officer.
On May 6, 2024, Gina Corradetti provided Accuray Incorporated (the “Company”) with notice of her intent to resign from her position as VP, Chief Accounting Officer and principal accounting officer, which resignation will be effective May 17, 2024, to pursue other opportunities.
On May 9, 2024, the Company’s Board of Directors appointed Ali Pervaiz, the Company’s Senior Vice President, Chief Financial Officer, to serve as the Company’s interim principal accounting officer, effective May 17, 2024 until a permanent successor is appointed.
Max materiality 0.90 · Median 0.55 · Most common event leadership